Cancer medicines

Bortezomib

Bortezomib

A proteasome inhibitor used in multiple myeloma and other settings.

Sources checked · Introductory guide

On this page

How it works

It inhibits proteasomes involved in protein processing to kill cancer cells.[2]

Where it is used

Used for multiple myeloma and selected mantle cell lymphoma settings.[1]

Key safety points

Report numbness, pain, weakness, fever or bleeding immediately. Seek prompt advice for a blistering rash.[2]

Questions for your care team

  • When should I report numbness, and how might treatment be adjusted?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Bortezomib (opens in a new tab)
  2. MedlinePlus · Bortezomib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Bortezomib | Cancer Encyclopedia | My Chemo Diary